EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)

Lijuan Wang, Chenjin Ruan

International Journal of Oncology · 06.10.2026 · 69 (5) · 1-18

DOI: 10.3892/ijo.2026.5943 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 06.10.2026. Verfasst von Lijuan Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University,…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Tumor Escape, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) represents the most prevalent type of lung cancer, accounting for 35‑40% of all lung cancer cases. Regulatory T cells (Tregs), a CD4+ T cell subtype with immunosuppressive functions, play a pivotal role in maintaining self‑tolerance under physiological conditions. Recent evidence has increasingly highlighted their involvement in various cancers. In LUAD, Treg infiltration into tissues undermines the immune anticancer response, correlating with disease stage, treatment efficacy and prognosis. By inhibiting robust anti‑tumor immune mechanisms, Tregs facilitate tumor immune escape in LUAD. Furthermore, elevated Treg cell accumulation in LUAD has been linked to reduced overall survival rates. Tregs serve as independent predictors for LUAD diagnosis in patients at high risk of recurrence. Systematic depletion of all Tregs to enhance anticancer efficacy poses risks of inducing severe autoimmune pathologies. Consequently, understanding the precise structure of tumor‑infiltrating Tregs is essential for effective targeting of these cells in tumors. Additionally, identifying candidate targets or methods for the specific elimination of tumor‑infiltrating Tregs is necessary for developing efficient and safe combination immunotherapy strategies for LUAD. The present study focuses on the regulatory role of Tregs in LUAD prognosis, immune escape and targeted therapies, elucidating the molecular mechanisms of Treg involvement and presenting associated therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryTumor EscapeLung NeoplasmsAdenocarcinoma of LungHumansPrognosisTumor MicroenvironmentLymphocytes, Tumor-InfiltratingImmunotherapyAnimals

Stichwörter der Autor:innen

immune escapelung adenocarcinomaprognosisregulatory T cellstumor microenvironment

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China.
  • Department of Thoracic Surgery, Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China.

Zitieren

APA

Wang, L., & Ruan, C. (2026). Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review). International Journal of Oncology, 69(5), 1-18. https://doi.org/10.3892/ijo.2026.5943

Vancouver

Wang L, Ruan C. Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review). International Journal of Oncology. 2026;69(5):1-18. doi:10.3892/ijo.2026.5943

BibTeX
@article{Wang2026,
  author = {Wang, Lijuan and Ruan, Chenjin},
  title = {Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)},
  journal = {International Journal of Oncology},
  year = {2026},
  volume = {69},
  number = {5},
  pages = {1--18},
  doi = {10.3892/ijo.2026.5943}
}
Kostenlos starten →